Insulin sensitivity and Lp(α) concentrations in normoglycemic offspring of type 2 diabetic parents

Lipids in Health and Disease

Volumn 2, Issue , 2003, Pages 1-6

  Psyrogiannis, Agathoklis ^a   Habeos, Ioannis ^a   Kyriazopoulou, Venetsana ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHILD PARENT RELATION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 3042531086     PISSN: 1476511X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-511X-2-1     Document Type: Article

References (47)

1. Reaven GM: Insulin resistance in non-insulin dependent diabetes mellitus does it exist and can it be measured? Am J Med 1983, Suppl 1A:3-17.
2. De Fronzo RA, Bonadonna RC and Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1999, 15:318-368.
3. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J and Raskin P: Relationship between lipoprotein levels and in vivo insulin action in normal white men. Metabolism 1988, 37:982-987.
4. Mykkanen L, Haffner SM, Ronnemaa L, Lehto S, Ronnemaa T, Pyorala K and Laakso M: Is there a sex difference in the association of insulin levels and insulin sensitivity with lipids and lipoproteins? Metabolism 1994, 43:523-528.
5. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L and Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
6. 1/2 year follow-up of the Helsinki Policeman population. Acta Med Scand 1985, 701(Suppl):38-52.
7. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR and Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia 1980, 19:205-210.
8. Berg K: A new serum type system in man - The Lp system. Acta Pathol Microbiol Scand 1963, 59:369-382.
9. Utermann G: The mysteries of lipoprotein (α). Science 1989, 246:904-910.
10. Scann AM and Fress GM: Heterogeneity and biological relevance. J Clin Invest 1990, 85:1709-1715.
11. Berg K, Dahlen G and Frick MH: Lp(α) lipoprotein and pre-beta lipoprotein in patients with coronary heart disease. Clin Genet 1974, 6:230-235.
12. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA and Gotto AM Jr: Association of levels of lipoprotein LP(α), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986, 74:758-765.
13. Sandholzer C, Boerwinkle E, Saha N, Tong MC and Utermann G: Apolipoprotein (α) phenotypes Lp(α) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: Evidence for the role of the Apo (α) Gene in Coronary Heart Disease. J Clin Invest 1992, 89:1040-1046.
14. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, Hoppichler F, Boerwinkle E and Utermann G: Apo(α) isoforms predict risk for Coronary Heart Disease. A study in six populations. Arteriosclerosis Thromb 1992, 12:1214-1226.
15. Mohan V, Deepa R, Haranath SP, Premalatha G, Rema M, Sastry NG and Enas EA: Lipoprotein (α) is an Independent Risk Factor for Coronary Artery Disease in NIDDM Patients in South India. Diabetes Care 1998, 21:1819-1823.
16. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV and Raskin P: Lipoprotein (α) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 1992, 117:42-47.
17. Ishida Y, Kazumi T and Yoshida M: Serum lipoprotein (α) in patients with non-insulin-dependent diabetes mellitus (Abstract). Diabetes 1991, 40(Suppl 1):188A.
18. Heller FR, Jamart J, Honore P, Derue G, Novik V, Galanti L, Parfonry A, Hondekijn JC and Buysschaert M: Serum lipoprotein (α) in patients with diabetes mellitus. Diabetes Care 1993, 16:819-823.
19. Haffner SM, Morales PA, Stern MP and Gruber MK: Lp(α) concentrations in NIDDM. Diabetes 1992, 41:1267-1272.
20. Sundell IB, Nilsson TK, Hallmans G, Hellsten G and Dahlen GH: Interrelations between plasma levels of plasminogen activator inhibitor, tissue plasminoger activator, lipoprotein (α), and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 1989, 80:9-16.
21. Haffner SM, Gruber KK, Morales PA, Hazuda HP, Valdez RA, Mitchell BD and Stern MP: Lipoprotein (α) concentrations in Mexican Americans and non-Hispanic whites: The San Antonio Heart Study. Am J Epidemiol 1992, 136:1060-1068.
22. Haffner SM, Karhapaa P, Rainwater DL, Mykkanen L, Aldrete G Jr and Laakso M: Insulin sensitivity and Lp(α) concentrations in Normoglycemic men. Diabetes Care 1995, 18:193-199.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
24. Haffner SM, Kennedy E, Gonzalez C, Stern MP and Miettinen H: A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996, 19:1138-1146.
25. Duncan MH, Singh BM, Wise PH, Carter G and Alaghband-Zadeh J: A single measure of insulin resistance in human disease. Lancet 1995, 346:120-121.
26. Duncan MH, Singh BM, Wise PH, Carter G and Alaghband-Zadeh J: Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis (IRAS) Investigators. Ann Epidemiol 1998, 8:358-369.
27. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T and Muggeo M: Homeostasis model assessment closely mirrows the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 2000, 23:57-63.
28. Friedewald WT, Lery RI and Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
29. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K and Nakai Y: Remnant-like particle cholesterol, triglycerides and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000, 23:1766-1769.
30. Barnett AH, Eff C, Leslie RD and Pyke DA: Diabetes in identical twins: A study of 200 pairs. Diabetologia 1981, 20:87-93.
31. Ho LT, Chang ZY, Wang JT, Li SH, Liu YF, Chen YD and Reaven GM: Insulin insensitivity in offspring of parents with type 2 diabetes mellitus. Diabetic Medicine 1990, 7:31-34.
32. Ganesh RDG, Volkmann A and Leslie HP et al.: Insensitivity to insulin in offspring of non-insulin dependent diabetic patients. Diabetes Nutrition Metabolism 1988, 3:235-237.
33. Haffner SM, Stern MP, Hazuda HP, Mitchell BD and Patterson JK: Increased insulin concentrations in non-diabetic offspring of diabetic parents. N Engl J Med 1988, 319:1297-1301.
34. Leslie RD, Volkmann HP, Poncher M, Hanning I, Orskov H and Alberti KG: Metabolic abnormalities in children of non-insulin dependent diabetics. Brit Med J 1986, 293:840-841.
35. Haffner SM, Tattle KR and Rainwater DL: Decrease of lipoprotein (α) with improved glycemic control in IDDM subjects. Diabetes Care 1991, 14:302-307.
36. Kapelrud H, Bangstad HJ, Dahl-Jorgensen K, Berg K and Hanssen KF: Serum Lp(α) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. Brit Med. J 1991, 3:675-678.
37. Levutsky LL, Scanu AM and Gould SH: Lipoprotein (α) levels in black and white children and adolescents with IDDM. Diabetes Care 1991:283-287.
38. Nakata H, Horita K and Eto M: Alteration of lipoprotein (α) concentration with glycaemic control in non-insulin dependent diabetic subjects without complications. Metabolism 1993:1323-1326.
39. Ritter MM, Loscar M, Richter WO and Schwandt P: Lipoprotein (α) in diabetes mellitus. Clinica Chimica Acta 1993, 4:45-54.
40. Winocour PH, Bhatnagar D, Ishola M, Arrol S and Durrington PN: Lipoprotein (α) and microvascular disease in type 1 (insulin dependent) diabetes mellitus. Diabetic Medicine 1991:922-927.
41. Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M and Arrol S: A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin dependent) diabetes mellitus. Diabetes Research and Clinical Practice 1992, 8:173-184.
42. Wolffenbuttel BH, Leurs PB, Sels JP, Rondas-Colbers GJ, Menheere PP and Nieuwenhuijzen Kruseman AC: Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein (α) levels. Diabetic Medicine 1993, 10:427-430.
43. Sidhu M, Crook D, Godsland IF, Walton C, Wynn V and Oliver MF: Inverse relationship between Lp(α) levels and first-phase insulin secretion. Diabetes 1992, 41:1341-1345.
44. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG and Seitz C: Lp(α) glycoprotein phenotypes:inheritance and relation of Lp(α) - lipoprotein concentrations in plasma. J Clin Invest 1987, 80:458-465.
45. Rainwater DL, Manis GS and Vandeberg JL: Hereditary and dietary effects on apolipoprotein (α) isoforms and Lp(α) in baboons. J Lipid Res 1989, 30:549-558.
46. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G and Hobbs HH: Apolipoprotein (α) gene accounts for greater than 90% of the variation in plasma lipoprotein (α) concentrations. J Clin Invest 1992, 90:52-60.
47. Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W and Morrisett JD: Polymorphic forms of human apolipoprotein (α): inheritance and relationship of their molecular weights to plasma levels of lipoprotein (α). J Lipid Res 1990, 31:603-6.